---
schema_version: "secwatch.filing_event.v1"
accession: "0001378325-25-000002"
form_type: "8-K"
ticker: "CV"
cik: "0001378325"
company_name: "CapsoVision, Inc"
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:37:18.017284+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CapsoVision signs $4.1M CMOS sensor development agreement with Canon; overallotment yields $0.6M

## Summary
- Development agreement with Canon for CMOS image sensor samples; total fee ~$4.1M, $1M cash upfront, remainder via unit price add-on in future purchase agreement.
- Samples to be used for evaluation, clinical evaluation, and FDA 510(k) clearance for future capsule endoscopy products.
- Capso submitted FDA 510(k) for first-generation CapsoCam Colon on June 10, 2025; second generation planned before commercialization.
- Underwriters exercised partial overallotment: 129,978 shares issued for net proceeds ~$600,000; additional warrants for 3,898 shares at $6.25 exercise price.

## SEC filing metadata
- accession: 0001378325-25-000002
- form_type: 8-K
- ticker: CV
- cik: 0001378325
- company_name: CapsoVision, Inc
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1378325/000137832525000002/0001378325-25-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1378325/000137832525000002/cv-20250715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001378325-25-000002
- JSON: https://secwatch.observer/filing/0001378325-25-000002.json
- Plain text: https://secwatch.observer/filing/0001378325-25-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.